Have your own idea? Try our Stock Screener
German (DAX) Pharma Industry Analysis
UpdatedApr 02, 2026
DataAggregated Company Financials
Companies9
- 7D4.4%
- 3M-2.2%
- 1Y15.1%
- YTD-2.6%
Over the last 7 days, the Pharma industry has risen 4.4%, driven by gains in Bayer and Merck KGaA of 5.2% and 3.5%, respectively. During this same period, the Cantourage Group underperformed, falling 5.9%. In the last 12 months, the industry was up 15%. As for the next few years, earnings are expected to grow by 28% per annum.
Industry Valuation and Performance
Has the German Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 02 Apr 2026 | €89.9b | €67.9b | -€900,264,256.64 | 19.9x | -99.9x | 1.3x |
| Sat, 28 Feb 2026 | €99.4b | €68.3b | €2.9b | 18.7x | 34.7x | 1.5x |
| Mon, 26 Jan 2026 | €102.0b | €68.3b | €2.9b | 17.7x | 35.6x | 1.5x |
| Wed, 24 Dec 2025 | €90.5b | €68.3b | €2.9b | 17.8x | 31.6x | 1.3x |
| Fri, 21 Nov 2025 | €77.6b | €68.5b | €2.9b | 16.4x | 26.9x | 1.1x |
| Sun, 19 Oct 2025 | €78.1b | €68.8b | -€439,012,678.07 | 19.5x | -178x | 1.1x |
| Tue, 16 Sep 2025 | €76.5b | €68.9b | -€406,230,056.92 | 16.9x | -188.2x | 1.1x |
| Thu, 14 Aug 2025 | €77.7b | €68.9b | -€409,978,364.74 | 16.9x | -189.4x | 1.1x |
| Sat, 12 Jul 2025 | €79.5b | €69.4b | -€283,071,598.00 | 17.9x | -281x | 1.1x |
| Mon, 09 Jun 2025 | €78.7b | €69.4b | -€206,268,848.00 | 18.5x | -381.3x | 1.1x |
| Wed, 07 May 2025 | €80.1b | €69.3b | €463.8m | 19x | 172.8x | 1.2x |
| Fri, 04 Apr 2025 | €76.6b | €69.3b | €467.0m | 18.2x | 163.9x | 1.1x |
| Sun, 02 Mar 2025 | €84.1b | €69.2b | €2.0b | 21.9x | 41.5x | 1.2x |
| Tue, 28 Jan 2025 | €86.4b | €69.2b | €2.0b | 23.4x | 43x | 1.2x |
| Thu, 26 Dec 2024 | €81.1b | €69.2b | €2.0b | 22.2x | 40.4x | 1.2x |
| Sat, 23 Nov 2024 | €83.7b | €69.2b | €2.0b | 22.3x | 41.3x | 1.2x |
| Mon, 21 Oct 2024 | €99.9b | €69.4b | €1.6b | 21.1x | 64x | 1.4x |
| Wed, 18 Sep 2024 | €101.9b | €69.3b | €1.5b | 25.2x | 69.1x | 1.5x |
| Fri, 16 Aug 2024 | €102.0b | €69.3b | €1.5b | 31x | 70x | 1.5x |
| Sun, 14 Jul 2024 | €96.1b | €69.2b | -€303,627,757.00 | 29.4x | -316.3x | 1.4x |
| Tue, 11 Jun 2024 | €104.7b | €69.2b | -€328,028,608.00 | 20.9x | -319.1x | 1.5x |
| Thu, 09 May 2024 | €97.5b | €70.0b | -€71,338,132.02 | 20.3x | -1367.3x | 1.4x |
| Sat, 06 Apr 2024 | €95.3b | €70.0b | -€34,208,180.00 | 20.6x | -2786.6x | 1.4x |
| Mon, 04 Mar 2024 | €99.2b | €70.6b | -€650,504,143.00 | 19.8x | -152.5x | 1.4x |
| Wed, 31 Jan 2024 | €98.1b | €70.6b | -€647,396,793.00 | 21.6x | -151.5x | 1.4x |
| Fri, 29 Dec 2023 | €97.7b | €70.6b | -€650,606,256.00 | 19.4x | -150.1x | 1.4x |
| Sun, 26 Nov 2023 | €104.6b | €70.6b | -€653,407,256.00 | 19.8x | -160.2x | 1.5x |
| Tue, 24 Oct 2023 | €105.8b | €72.1b | €4.7b | 18.3x | 22.6x | 1.5x |
| Thu, 21 Sep 2023 | €120.8b | €72.1b | €4.7b | 21.8x | 25.8x | 1.7x |
| Sat, 19 Aug 2023 | €121.8b | €72.1b | €4.7b | 22.5x | 26x | 1.7x |
| Mon, 17 Jul 2023 | €117.4b | €74.1b | €6.5b | 18.2x | 18.2x | 1.6x |
| Wed, 14 Jun 2023 | €126.8b | €74.1b | €6.4b | 22.6x | 19.8x | 1.7x |
| Fri, 12 May 2023 | €127.8b | €74.2b | €7.6b | 21.6x | 16.9x | 1.7x |
| Sun, 09 Apr 2023 | €139.0b | €74.2b | €7.6b | 19.7x | 18.2x | 1.9x |
Price to Earnings Ratio
18.2x
Current Industry PE
- Investors are relatively neutral on the German Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PS ratio of 1.4x.
Past Earnings Growth
- Total earnings for the Pharmaceuticals industry have declined over the last three years, with the industry now making a loss overall.
- Revenues have also declined 2.9% per year, which is driving profits down.
Industry Trends
Which industries have driven the changes within the German Healthcare industry?
| DE Market | 1.21% | |
| Healthcare | 1.58% | |
| Pharma | 4.38% | |
| Pharma | 4.38% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| BAYN Bayer | €40.12 | 5.2% +€2.0b | 87.3% | PS0.9x | |
| MRK Merck KGaA | €109.90 | 3.5% +€1.6b | -12.8% | PE18.3x | |
| DMP Dermapharm Holding | €46.45 | 8.9% +€204.6m | 26.4% | PE21.6x | |
| 93M1 MPH Health Care | €18.75 | 5.9% +€4.5m | -24.4% | PB0.4x | |
| B8FK Biofrontera | €2.58 | 2.8% +€425.4k | 3.8% | PS0.7x |
